Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 51655-115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 51655-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 115 25)

NDC 51655-115-25 is a medication called bupropion HCI, in the form of extended-release tablets with a strength of 150mg. It is only available with a prescription and should be taken twice a day after initial titration. The tablets should be stored in their original container at a controlled room temperature, between 20-25°C (68-77°F) and kept out of reach of children. Do not use this medication with other medicines containing bupropion HCI. This particular package was repackaged by Northwind Pharmaceuticals from a Lot number 70436-059-XX and contains an expiration date of 00/00/0000.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.